The muscle's own damage repair signal
Mechano Growth Factor (MGF) is an alternatively spliced isoform of the IGF-1 gene — specifically the IGF-1Ec isoform produced when the IGF-1 gene is spliced in response to mechanical stress or tissue damage. When you train, tear muscle fibres, or sustain an injury, the local tissue upregulates this specific splice variant to initiate repair. It is the body's own localised muscle repair signal, distinct from the systemic IGF-1 produced by the liver in response to GH.
The critical distinction from IGF-1 LR3: MGF acts primarily through a receptor separate from IGF-1R — likely involving the extracellular signal domain of the E-peptide — and drives satellite cell activation through the MAPK-Erk1/2 pathway independently of the PI3K/Akt pathway that dominates IGF-1R signalling. This means MGF and IGF-1 are not redundant — they stimulate different aspects of the repair and hypertrophy process and can be used together synergistically.
The problem with native MGF is its ~5 minute half-life — almost useless for systemic administration. PEG-MGF (PEGylated MGF) conjugates polyethylene glycol (PEG) chains to the peptide, dramatically increasing plasma half-life to several days. This enables systemic administration with once-weekly dosing and produces sustained satellite cell activation throughout the body rather than locally. PEG-MGF is the practical form most community users employ; native MGF is used by some for local site injections immediately post-workout.
Satellite cells, MAPK pathway, and PEGylation
Mechanism of Action
What people report
"PEG-MGF 200mcg twice weekly for 6 weeks post-injury (partial bicep tear). Combined with BPC-157 and TB-500. Recovery timeline was faster than both previous injuries without peptides. Hard to attribute causation but the combination felt qualitatively different — the affected muscle seemed to remodel more completely."
Male, 34. The combination of PEG-MGF (satellite cell activation), BPC-157 (angiogenesis and growth factor expression), and TB-500 (actin dynamics and cell migration) covers three non-overlapping mechanisms of tissue repair. This triple-stack has become a community standard for significant muscle injuries.
"Native MGF 200mcg site-injected into each quad immediately after heavy squats, twice weekly. Within 3 weeks: meaningful increase in quad fullness and recovery speed. The localised effect is distinctly different from systemic peptides — you can feel the difference in the specific muscle."
Male, 27, competitive powerlifter. Site injection of native MGF immediately post-workout is the community's most direct application of the physiological rationale — replicating the local repair signal that exercise itself induces, but at a higher concentration and more sustained presence than endogenous production provides.
Risks & considerations
Editor's summary
MGF and PEG-MGF occupy a distinct niche — local muscle repair and satellite cell activation through a pathway non-redundant with IGF-1. The physiological rationale is excellent: this is exactly what the muscle produces in response to mechanical damage, and exogenous administration replicates and amplifies that signal. The community evidence for injury recovery and localised hypertrophy is consistent over many years of use.
The choice between native MGF (site injection, local effect, impractical for systemic use) and PEG-MGF (systemic, sustained, once-weekly) depends entirely on the application. Injury recovery with localised target: native MGF + BPC-157 + TB-500. Broad anabolic stimulus alongside IGF-1 LR3: PEG-MGF systemically. The two forms are not interchangeable — they have different pharmacokinetics and use cases.